LPA (lysophosphatidic acid), a pro-fibrotic, inflammatory mediator and also a downstream metabolite of Phospholipase A2 (PLA2) signaling was found to be increased in both BAL fluid of IPF patients and bleomycin-treated mice. The gene discussed is PLA2G2A; the disease is idiopathic pulmonary fibrosis.